Pfizer Stock Options
| PFE Stock | USD 26.27 0.05 0.19% |
Pfizer's option chain provides insight into all available option contracts written on Pfizer's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Pfizer's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Pfizer option contract.
In The Money vs. Out of Money Option Contracts on Pfizer
Analyzing Pfizer's in-the-money options over time can help investors to take a profitable long position in Pfizer regardless of its overall volatility. This is especially true when Pfizer's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Pfizer's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Pfizer's stock while costing only a fraction of its price.
Pfizer's latest option contracts expiring on 2024-04-26 are carrying combined implied volatility of 37.22 with a put-to-call open interest ratio of 0.48 over 76 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-04-26. The current put volume is at 6252, with calls trading at the volume of 12158. This yields a 0.51 put-to-call volume ratio. The Pfizer option chain provides detailed quote and price information for the current Pfizer Inc option contracts. It shows all of Pfizer's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-04-26 Option Contracts
Pfizer option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Pfizer's lending market. For example, when Pfizer's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Pfizer, he or she must hedge the risk by shorting Pfizer stock over its option's life.
2024-04-26
The chart above shows Pfizer's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Pfizer's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Pfizer's option, there is no secondary market available for investors to trade.
Pfizer Maximum Pain Price across 2024-04-26 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Pfizer close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Pfizer's stock options are financial instruments that give investors the right to buy or sell shares of Pfizer Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Pfizer stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Pfizer's stock price goes up or down, the stock options follow.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Please note that buying 'in-the-money' options on Pfizer lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Pfizer's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Pfizer contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Pfizer Stock moves the wrong way.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to 0.00, whereas Other Stockholder Equity is projected to grow to (20.8 B). Pfizer Inc In The Money Call Balance
When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying Pfizer's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Pfizer Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Pfizer Current Options Market Mood
Pfizer's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Pfizer Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Pfizer's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Pfizer's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Pfizer's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Pfizer contract
Base on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 2.33% per day over the life of the 2024-04-26 option contract. With Pfizer trading at USD 26.27, that is roughly USD 0.61. If you think that the market is fully incorporating Pfizer's daily price movement you should consider buying Pfizer Inc options at the current volatility level of 37.22%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Pfizer |
Purchasing Pfizer options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Pfizer calls. Remember, the seller must deliver Pfizer Inc stock to the call owner when a call is exercised.
Pfizer Option Chain
When Pfizer's strike price is surpassing the current stock price, the option contract against Pfizer Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-04-262024-05-032024-05-102024-05-172024-05-242024-05-312024-06-212024-07-192024-08-162024-09-202024-10-182024-12-202025-01-172025-03-212025-06-202025-12-192026-01-162026-06-18
Pfizer's option chain is a display of a range of information that helps investors for ways to trade options on Pfizer. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Pfizer. It also shows strike prices and maturity days for a Pfizer against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-04-26 CALL at $15.0 | 0.9757 | 0.007 | 1 | 2024-04-26 | 11.15 - 11.65 | 11.43 | In |
Call | 2024-04-26 CALL at $16.0 | 0.9034 | 0.0139 | 4 | 2024-04-26 | 9.55 - 12.45 | 9.4 | In |
Call | 2024-04-26 CALL at $17.0 | 0.9451 | 0.014 | 35 | 2024-04-26 | 8.7 - 10.35 | 8.8 | In |
Call | 2024-04-26 CALL at $17.5 | 0.9755 | 0.0099 | 5 | 2024-04-26 | 8.2 - 9.55 | 8.3 | In |
Call | 2024-04-26 CALL at $18.0 | 0.8847 | 0.0197 | 5 | 2024-04-26 | 7.8 - 10.15 | 8.1 | In |
Call | 2024-04-26 CALL at $19.0 | 0.9484 | 0.0188 | 1 | 2024-04-26 | 6.75 - 8.15 | 6.55 | In |
Call | 2024-04-26 CALL at $20.0 | 0.8599 | 0.0287 | 58 | 2024-04-26 | 5.65 - 6.95 | 6.32 | In |
Call | 2024-04-26 CALL at $21.0 | 0.9613 | 0.0239 | 2 | 2024-04-26 | 4.7 - 6.05 | 5.0 | In |
Call | 2024-04-26 CALL at $22.0 | 0.9542 | 0.0332 | 163 | 2024-04-26 | 3.6 - 5.15 | 3.34 | In |
Call | 2024-04-26 CALL at $22.5 | 0.9043 | 0.0513 | 86 | 2024-04-26 | 3.05 - 4.9 | 3.05 | In |
Call | 2024-04-26 CALL at $23.0 | 0.848 | 0.0635 | 57 | 2024-04-26 | 2.86 - 4.4 | 3.3 | In |
Call | 2024-04-26 CALL at $23.5 | 0.8554 | 0.0766 | 1 | 2024-04-26 | 2.6 - 3.5 | 2.2 | In |
Call | 2024-04-26 CALL at $24.0 | 0.815 | 0.0926 | 348 | 2024-04-26 | 2.25 - 3.0 | 2.36 | In |
Call | 2024-04-26 CALL at $24.5 | 0.8605 | 0.1235 | 286 | 2024-04-26 | 1.75 - 2.11 | 1.95 | In |
Call | 2024-04-26 CALL at $25.0 | 0.8894 | 0.1676 | 845 | 2024-04-26 | 1.22 - 1.38 | 1.38 | In |
Call | 2024-04-26 CALL at $25.5 | 0.7626 | 0.2571 | 3605 | 2024-04-26 | 0.67 - 0.99 | 0.82 | In |
Call | 2024-04-26 CALL at $26.0 | 0.685 | 0.5192 | 12766 | 2024-04-26 | 0.46 - 0.48 | 0.46 | In |
Call | 2024-04-26 CALL at $26.5 | 0.3955 | 0.5916 | 20682 | 2024-04-26 | 0.18 - 0.2 | 0.18 | Out |
Call | 2024-04-26 CALL at $27.0 | 0.1665 | 0.3642 | 17608 | 2024-04-26 | 0.05 - 0.06 | 0.06 | Out |
Call | 2024-04-26 CALL at $27.5 | 0.0625 | 0.1647 | 4526 | 2024-04-26 | 0.01 - 0.02 | 0.02 | Out |
Call | 2024-04-26 CALL at $28.0 | 0.0497 | 0.1049 | 4768 | 2024-04-26 | 0.0 - 0.01 | 0.02 | Out |
Call | 2024-04-26 CALL at $29.0 | 0.0219 | 0.0417 | 3744 | 2024-04-26 | 0.0 - 0.02 | 0.01 | Out |
Call | 2024-04-26 CALL at $30.0 | 0.0175 | 0.0268 | 2908 | 2024-04-26 | 0.0 - 0.01 | 0.01 | Out |
Put | 2024-04-26 PUT at $40.0 | -0.9864 | 0.0072 | 0 | 2024-04-26 | 13.05 - 14.35 | 0.0 | In |
Put | 2024-04-26 PUT at $38.0 | -0.973 | 0.013 | 0 | 2024-04-26 | 10.75 - 12.7 | 0.0 | In |
Put | 2024-04-26 PUT at $37.0 | -0.8683 | 0.0298 | 0 | 2024-04-26 | 10.15 - 11.1 | 10.85 | In |
Put | 2024-04-26 PUT at $36.0 | -0.9836 | 0.0109 | 0 | 2024-04-26 | 8.95 - 10.45 | 0.0 | In |
Put | 2024-04-26 PUT at $35.0 | -0.8113 | 0.0368 | 0 | 2024-04-26 | 8.0 - 10.7 | 0.0 | In |
Put | 2024-04-26 PUT at $34.0 | -0.9225 | 0.0324 | 1 | 2024-04-26 | 6.95 - 8.7 | 7.7 | In |
Put | 2024-04-26 PUT at $33.5 | -0.9397 | 0.0306 | 0 | 2024-04-26 | 6.4 - 8.15 | 0.0 | In |
Put | 2024-04-26 PUT at $33.0 | -0.7916 | 0.045 | 0 | 2024-04-26 | 6.05 - 8.65 | 0.0 | In |
Put | 2024-04-26 PUT at $32.5 | -0.7773 | 0.0474 | 0 | 2024-04-26 | 5.35 - 6.9 | 0.0 | In |
Put | 2024-04-26 PUT at $32.0 | -0.7786 | 0.0508 | 0 | 2024-04-26 | 5.0 - 6.35 | 0.0 | In |
Put | 2024-04-26 PUT at $31.5 | -0.7471 | 0.0528 | 0 | 2024-04-26 | 4.3 - 6.0 | 5.55 | In |
Put | 2024-04-26 PUT at $31.0 | -0.9542 | 0.0386 | 0 | 2024-04-26 | 3.75 - 5.7 | 3.36 | In |
Put | 2024-04-26 PUT at $30.5 | -0.9186 | 0.0561 | 0 | 2024-04-26 | 3.3 - 5.25 | 0.0 | In |
Put | 2024-04-26 PUT at $30.0 | -0.8861 | 0.0703 | 10 | 2024-04-26 | 2.95 - 4.7 | 4.05 | In |
Put | 2024-04-26 PUT at $29.5 | -0.8287 | 0.0851 | 0 | 2024-04-26 | 2.63 - 4.25 | 3.95 | In |
Put | 2024-04-26 PUT at $29.0 | -0.8742 | 0.0961 | 216 | 2024-04-26 | 2.49 - 2.9 | 2.81 | In |
Put | 2024-04-26 PUT at $28.5 | -0.8094 | 0.1192 | 0 | 2024-04-26 | 1.48 - 2.41 | 0.0 | In |
Put | 2024-04-26 PUT at $28.0 | -0.8277 | 0.1529 | 588 | 2024-04-26 | 1.46 - 2.34 | 1.83 | In |
Put | 2024-04-26 PUT at $27.5 | -0.9034 | 0.1949 | 11 | 2024-04-26 | 0.93 - 1.46 | 1.22 | In |
Put | 2024-04-26 PUT at $27.0 | -0.9143 | 0.3199 | 2695 | 2024-04-26 | 0.66 - 0.74 | 0.76 | In |
Put | 2024-04-26 PUT at $26.5 | -0.612 | 0.6287 | 1982 | 2024-04-26 | 0.33 - 0.36 | 0.32 | In |
Put | 2024-04-26 PUT at $26.0 | -0.3071 | 0.5382 | 12245 | 2024-04-26 | 0.12 - 0.14 | 0.13 | Out |
Put | 2024-04-26 PUT at $25.5 | -0.131 | 0.283 | 4443 | 2024-04-26 | 0.03 - 0.05 | 0.05 | Out |
Put | 2024-04-26 PUT at $25.0 | -0.0713 | 0.1457 | 7744 | 2024-04-26 | 0.02 - 0.03 | 0.03 | Out |
Put | 2024-04-26 PUT at $24.5 | -0.0264 | 0.0622 | 2105 | 2024-04-26 | 0.0 - 0.02 | 0.01 | Out |
Put | 2024-04-26 PUT at $24.0 | -0.0478 | 0.0671 | 1537 | 2024-04-26 | 0.0 - 0.01 | 0.03 | Out |
Pfizer Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Pfizer Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Pfizer Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Pfizer Corporate Directors
Pfizer corporate directors refer to members of a Pfizer board of directors. The board of directors generally takes responsibility for the Pfizer's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Pfizer's board members must vote for the resolution. The Pfizer board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Shantanu Narayen | Lead Independent Director | Profile | |
| Susan DesmondHellmann | Independent Director | Profile | |
| Stephen Sanger | Independent Director | Profile | |
| James Quincey | Independent Director | Profile |
Already Invested in Pfizer Inc?
The danger of trading Pfizer Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Pfizer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Pfizer. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Pfizer Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Dividend Share 1.64 | Earnings Share 0.37 | Revenue Per Share 10.366 | Quarterly Revenue Growth (0.41) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.